Daily as of 3 Nov 16:00 ET
- Price
- below both $25.44 vs 50 $35.76 / 200 $35.63
- Projection
- 💀Death cross projected in 1 bar
- Test
- No active test
- Last cross
- 🟨Golden cross 28 Aug 2025 · projected 30 bars out · tested 1 bar
RAPP | Rapport TherapeuticsNASDAQHealthcareCommon stock golden cross and death cross projections, cross tests and history
$25.44
+$0.31 (+1.23%)
Rapport Therapeutics (RAPP) is a NASDAQ-listed common stock that Cruxta has tracked for 50/200 crosses since 2025.
Right now the daily is the chart to watch. The 50 SMA has sat above the 200 since Aug 2025, but the two have been closing on each other and a death cross is projected within 10 bars. Price sits below the 50 and the 200 on the daily and the 4-hour.
Timeframe summary
Weekly
No weekly data
4-hour as of 3 Nov 13:30 ET
- Price
- below both $25.29 vs 50 $28.54 / 200 $39.10
- Projection
- No cross projected
- Test
- No active test
- Last cross
- 💀Death cross 2 Oct 2026 · projected 19 bars out
Cross history
| Crossed | Direction | Timeframe | Projected | Cross test |
|---|---|---|---|---|
| 2 Oct 2026 | 💀Death | 4-hour | 19 bars out | Not tested |
| 28 Aug 2025 | 🟨Golden moderate | daily | 30 bars out | 1 bar cross test |
About RAPP
ExchangeNASDAQ
InstrumentCommon stock
Median $ volume, 60 d$14.4M
4-hour coverageYes, since Oct 2025
History on recordSince 2025
SectorHealthcare
Cap bandmid